Patrick J. Perik

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2006 · 308 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab

Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik et al. · British Journal of Pharmacology · 2004 · 177 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity

M.A. de Korte, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge et al. · European Journal of Cancer · 2007 · 161 citations

Medicine, Cardiology, Pharmacology +16

Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity

Patrick J. Perik, Bart Rikhof, Floris A. de Jong et al. · Annals of Oncology · 2007 · 63 citations · Full text

Medicine, Cardiology, Internal Medicine +10

Serum HER2 Levels are Increased in Patients with Chronic Heart Failure

Patrick J. Perik, Elisabeth G.E. de Vries, Jourik A. Gietema et al. · European Journal of Heart Failure · 2006 · 55 citations

Medicine, Cardiology, Molecular Medicine +6